| Name | Title | Contact Details |
|---|
ContextVision is a leading provider of medical image enhancement software to global equipment manufacturers. With its versatile GOP® technology at the core of its extensive product line, ContextVision enables its customers to offer clinicians unparalleled diagnostic image quality, ultimately providing patients with better care. ContextVision was established in 1983 by a specialist research team at Linköping University in Sweden. The university has been a center for digital image research and analysis. ContextVision, now considered the gold standard of medical image enhancement, offers a powerful combination of sophisticated technology and team expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, interventional radiology and computed tomography. More than 150,000 systems across the globe rely on ContextVision`s market-leading products for 2D, 3D, or 4D image enhancements. Its dynamic group of image-enhancement experts customize installations for optimal image quality.
We develop game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
The HealthCentral Network, Inc. has a collection of owned and operated Web sites and multimedia affiliate properties providing timely, in-depth, trusted medical information, personalized tools and resources, and connections to a vast community of leading experts and patients
AccuStandard is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient`s own physiologic response. The Company`s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical application by eliminating need for surgery, needles and permanent implants and shifting therapy into the home environment.